Dr scheinert leipzig

Youngest marriage

Jul 25, 2011 · The primary efficacy endpoint is primary patency at 1 year. Dr. Kenneth Rosenfield (Massachusetts General Hospital, Boston MA) and Prof. Dierk Scheinert (Heart Center Leipzig/Park Hospital, Leipzig Germany) are the co-principal investigators of the trial. "We are very pleased to be the first center to contribute to such an important trial. 360° campus tour of Leipzig University. Experience Leipzig University in a 360° video: with our virtual campus tour, you can take a look around various parts of the University from the comfort of your own home. Left, right, up, down – have a look in all directions and discover the campus in a panoramic view. Dr Dierk Scheinert (Heart Center Leipzig, Germany) presented the six-month results from the LEVANT I study, which randomized 101 patients with femoropopliteal disease to angioplasty, with or ... It is my pleasure today to be joined by 2 friends and colleagues: Dr. Dierk Scheinert, Professor of Medicine at the University of Leipzig, and Director of Angiology at the Park Hospital in Leipzig, Germany; as well as Ian Meredith. „Rotational thrombectomy is an efficient, safe and rapidly-working technique for the therapy of acute and subacute ischaemia of lower limbs. It has good potential to reduce the number of thrombolytic and open surgery procedures, and their risks, and opens the way for immediate treatment of residual and parallel lesions.” Prof. Scheinert is the Medical Director at University Hospital Leipzig and Head of the Center for Vascular Medicine, Angiology and Vascular Surgery. He is recognized internationally for his expertise in both coronary and peripheral vascular interventions. Prof. Dierk Scheinert, MD, is Head of the Departments of Angiology at the Heart Center-University of Leipzig and the Park Hospital, Leipzig, Germany. He has disclosed that he holds no financial interest in any product or manufacturer mentioned herein. Dr. Scheinert may be reached at [email protected] First Atherectomy Performed With Spectranetics’ Turbo-Tandem Device ... Leipzig-Sudost GmbH in Leipzig, Germany and was performed by Dr. med. Matthias Ulrich in collaboration with Professor Dr ... Novel concept for drug delivery in infrapopliteal arteries – The LIMBO trial Prof. Dr. med. Dierk Scheinert Division of Interventional Angiology Assistenzärztin in der Inneren Medizin, Kardiologie/ Angiologie im Herzzentrum Leipzig (Prof. Dr. med. G. Schuler) sowie in der Inneren Medizin/Angiologie im Parkkrankenhaus Leipzig (Prof. Dr. med. D. Scheinert) 12/2001-2/2002: Wissenschaftliche Assistentin C1, Universitätsklinikum Erlangen, Innere Medizin/Kardiologie (Prof. Dr. med. W.G. Daniel) Dr. Scheinert, Head of the Department of Angiology at the University of Leipzig Heart Center and Park Hospital, is the principal investigator in NovoStent's multi-center European study. "It is exciting to be the first center to implant the world's longest peripheral stent," said Dr Scheinert. ELGX Endologix Inc Positive Three-Year Results from the Ovation® European Post Market Registry Presented at 2017 LINC Symposium „Rotational thrombectomy is an efficient, safe and rapidly-working technique for the therapy of acute and subacute ischaemia of lower limbs. It has good potential to reduce the number of thrombolytic and open surgery procedures, and their risks, and opens the way for immediate treatment of residual and parallel lesions.” The trial is to investigate the safety and efficacy of the Ranger™ Drug Coated Balloon in comparison to the IN.PACT™ Drug Coated Balloon in patients with symptomatic femoropopliteal artery disease. All enrolled subjects will be followed through to 24 months to assess the incidence of restenosis by ultrasound and major adverse events (MAE). Prof Dr Dierk Scheinert presents a stent covered with medicine to be placed into the lower leg of a patient suffering from disturbed blood flow in Leipzig, Germany, 14 January 2011. The new method will be presented at the Leipzig Interventional Course from 19 to 22 January. Photo: Waltraud Grubitzsch „Rotational thrombectomy is an efficient, safe and rapidly-working technique for the therapy of acute and subacute ischaemia of lower limbs. It has good potential to reduce the number of thrombolytic and open surgery procedures, and their risks, and opens the way for immediate treatment of residual and parallel lesions.” It is my pleasure today to be joined by 2 friends and colleagues: Dr. Dierk Scheinert, Professor of Medicine at the University of Leipzig, and Director of Angiology at the Park Hospital in Leipzig, Germany; as well as Ian Meredith. Background Randomized trials of drug-eluting stents (DES) and drug-coated balloons (DCB) for femoropopliteal interventions reported superior patency rates for both strategies compared to standard balloon angioplasty. To date, head-to-head comparisons are missing. Objectives The authors sought to compare DES versus DCB for femoropopliteal lesions through 36 months. Methods Within a multicenter ... Objectives This study sought to report short- and long-term efficacy and safety outcomes of retrograde tibioperoneal access for endovascular treatment of chronic total occlusions (CTOs). Background Antegrade recanalization of peripheral CTO is associated with a high failure rate and retrograde puncture of tibioperoneal arteries has been adopted to overcome this limitation. Methods Within a ... Dr. Scheinert, who is with the University Hospital Leipzig in Leipzig, Germany, served as the Primary Investigator of the BIOLUX P-I trial. Results from BIOLUX P-I are in line with other scientific data suggesting that DCB treatment is a viable option and has the potential to become the standard for treating femoropopliteal arteries, stated the ... Dr. Scheinert, who is with the University Hospital Leipzig in Leipzig, Germany, served as the Primary Investigator of the BIOLUX P-I trial. Results from BIOLUX P-I are in line with other scientific data suggesting that DCB treatment is a viable option and has the potential to become the standard for treating femoropopliteal arteries, stated the ... This month, Dr. Mustapha interviews LINC Course Director Dierk Scheinert, MD. Professor Scheinert is Head of the Department of Medicine, Angiology and Cardiology at Park-Krankenhaus Leipzig and Head of the Department of Angiology at the University of Leipzig, Heart Center, Germany. Liebigstraße 20a, Haus 6 04103 Leipzig. Erste-Hilfe-Tipps. So finden Sie uns. Klinik und Poliklinik für Angiologie Liebigstraße 20, Haus 4 04103 Leipzig Novel concept for drug delivery in infrapopliteal arteries – The LIMBO trial Prof. Dr. med. Dierk Scheinert Division of Interventional Angiology What happened at LINC 2015 from iVascular s standpoint 01 Jena PD Dr. R. Aschenbach, University Hospital Jena 02 Leipzig Prof. Dr. Dierk Scheinert, University Hospital Leipzig 03 Bad Krozingen Prof. Dr. Thomas Zeller, Heart Center 04 Hamburg Dr. S. Sixt, Angiologikum 05 München PD Dr. M. Treitl, University Hospital 06 Berlin Prof. Dr. K. Brechtel, „Ihre Radiologen“ This month, Dr. Mustapha interviews LINC Course Director Dierk Scheinert, MD. Professor Scheinert is Head of the Department of Medicine, Angiology and Cardiology at Park-Krankenhaus Leipzig and Head of the Department of Angiology at the University of Leipzig, Heart Center, Germany. Dr Scheinert has served as a compensated consultant for Abbott Vascular, Biotronik, Boston Scientific, Cook Medical, Cordis, CR Bard, Gardia Medical, Hemoteq, Medtronic/Covidien, Ostial Inc, TriReme Medical, TriVascular, and Upstream Peripheral Technologies. Orchid DCB in Leipzig – real world experience Dierk Scheinert, MD Division of Interventional Angiology University Hospital Leipzig, Germany 2002- 2014: Assistenzärztin in der Inneren Medizin, Kardiologie/ Angiologie im Herzzentrum Leipzig (Prof. Dr. med. G. Schuler) sowie in der Inneren Medizin/Angiologie im Parkkrankenhaus Leipzig (Prof. Dr. med. D. Scheinert)